‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ [StocksToTrade Live]( Top Trade Idea From The Trading Desk of Tim Bohen Hey. Tim Bohen here. Today was a lot less exciting than yesterday, but Oracle delivered us the winners nonetheless… Crown ElectroKinetics Corp. (NASDAQ: CRKN) spiked this morning and we got the Oracle bullish signal just in time, when it was trading at $0.12. After topping out at $0.18, it had gained 51.33%.* Our proprietary Oracle system is just one of the tools I use to guide my trading decisions, but it’s a powerful one. If you’re interested in learning all about it and how it can work for you, tune into my [free live webinar tonight at 9 pm Eastern](. Our second biggest mover today was DermTech Inc. (NASDAQ: DMTK). Another morning popper, we got the signal at the onset of the spike…. After it reached its high, DMTK had returned 48.3%.* Take a look at the price action from today… DermTech Inc. (NASDAQ: DMTK) I’m not sure the show’s over for this one…It pulled back after the spike but might be headed for another high. If it dips and Oracle gives us a buy signal, it’s all systems go! We can’t ignore what every trader is talking about right now, Nvidia Corp. (NASDAQ: NVDA) earnings, which was released this evening. Find out how I plan to play it during my [Free live broadcast at 9 pm Eastern]( Tim Bohen Lead Trainer, StocksToTrade   [Click Here to Unsubscribe]( 13809 Research Boulevard, Suite 500, Austin, TX 78750 *Past performance does not indicate future results This is for informational purposes only as StocksToTrade is not registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. StocksToTrade cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. StocksToTrade in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, StocksToTrade accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns. Copyright © StocksToTrade.com